Biogen (BIIB) Current Assets (2016 - 2025)
Historic Current Assets for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $9.0 billion.
- Biogen's Current Assets rose 2034.79% to $9.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.0 billion, marking a year-over-year increase of 2034.79%. This contributed to the annual value of $9.0 billion for FY2025, which is 2034.79% up from last year.
- According to the latest figures from Q4 2025, Biogen's Current Assets is $9.0 billion, which was up 2034.79% from $8.9 billion recorded in Q3 2025.
- Over the past 5 years, Biogen's Current Assets peaked at $10.4 billion during Q2 2023, and registered a low of $6.7 billion during Q1 2021.
- In the last 5 years, Biogen's Current Assets had a median value of $7.9 billion in 2021 and averaged $8.2 billion.
- As far as peak fluctuations go, Biogen's Current Assets surged by 3635.01% in 2022, and later plummeted by 3185.67% in 2024.
- Biogen's Current Assets (Quarter) stood at $7.9 billion in 2021, then increased by 24.63% to $9.8 billion in 2022, then decreased by 29.94% to $6.9 billion in 2023, then grew by 8.71% to $7.5 billion in 2024, then grew by 20.35% to $9.0 billion in 2025.
- Its Current Assets stands at $9.0 billion for Q4 2025, versus $8.9 billion for Q3 2025 and $8.0 billion for Q2 2025.